Diabetes

BOCA RATON, Fla. — Diabetica Research Solutions is spreading the word about its diabetes energy formula with a new media program that targets the New York metropolitan area.

The targeted media program for DRSI ReStore! Energy — which now is available at Duane Reade and Rite Aid pharmacies in the area — supplements the brand's national television campaign, includes high saturation local commercial spots on television and radio, and internet banner ads to appear specifically on Web pages viewed by people in New York and the surrounding area.

BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.

Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.

ALEXANDRIA, Va. Musician and reality TV star Bret Michaels recently shared his struggles with Type 1 diabetes and related health issues with the American Diabetes Association's consumer magazine, Diabetes Forecast.

WESTPORT, Conn. — A diabetes community network is offering tips to diabetics that are traveling this holiday season.

DLife emphasized that since diabetes doesn't take a holiday, managing the condition shouldn't either. On its website, DLife.com, the company is offering such tips to diabetics as:

NEW YORK — Adding pharmacists to a primary care team could help diabetics better manage associated risks, according to a new study conducted by researchers from the University of Alberta.

Among 153 hypertensive Type 2 diabetes patients studied, 82 who had advice from a pharmacist were more likely to reach blood pressure treatment targets recommended by the Canadian Diabetes Association.

CHICAGO — A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the risk of cardiovascular disease compared with other diabetes treatments, the two companies said Wednesday.

According to a study presented at the American Heart Association’s scientific sessions in Chicago, use of Byetta (exenatide) was associated with a lower incidence of cardiovascular disease than insulin and several other drug classes.

NEW YORK and SAN DIEGO — A leading charitable funder of and advocate for Type 1 diabetes research and a drug maker have entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of an analog of the human hormone leptin in patients with Type 1 diabetes.

NEW YORK In recognition of Diabetes Awareness Month, Colgate Total is offering consumers tips to build good oral hygiene habits.

Citing a statistic from the Centers for Disease Control and Prevention, which noted the increased prevalence of gum disease among those with diabetes, the toothpaste brand has made the following recommendations to consumers: